Long-term Effects of Anti-VEGF Therapy versus Panretinal Photocoagulation on Retinal Vessel Caliber in Eyes with Proliferative Diabetic Retinopathy

Retinal Diseases

Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy

JAMA Ophthalmol

Alsoudi AF, Wai KM, Koo E, Parikh R, Mruthyunjaya P, Rahimy E

doi: 10.1001/jamaophthalmol.2024.3283

Retinal DiseasesSurgery and Intervention

Anti-vascular endothelial growth factor injections vs panretinal photocoagulation laser therapy for proliferative diabetic retinopathy - A systematic review and meta-analysis

Ophthalmol Retina

Macaron MM, Al Sabbakh N, Shami MZ, Akrobetu D, Bourdakos NE, Abdulsalam FAM, Nakanishi H, Than CA, Bakri SJ

doi: 10.1016/j.oret.2024.08.004

Retinal Diseases

Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database

Ophthalmol Retina

Ip M, Modi Y, Fekrat S, Gibson K, Boucher N, Arrisi P, Ishii F, Liu Y, Paris LP, Fenech M, Chi GC

doi: 10.1016/j.oret.2025.05.025

Retinal Diseases

Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy

Am J Ophthalmol

Anguita R, Desideri LF, Schwember P, Shah N, Ahmed S, Raharja A, Roth J, Sivaprasad S, Wickham L

doi: 10.1016/j.ajo.2024.10.019

Macular DiseasesRetinal Diseases

Macular Capillary Nonperfusion in Eyes With Stable Laser-Treated Proliferative Diabetic Retinopathy

JAMA Ophthalmol

Thottarath S, Tsai WS, Gurudas S, Pearce E, Cheung CMG, Yamaguchi TCN, Sivaprasad S

doi: 10.1001/jamaophthalmol.2024.5105

Ocular Oncology

Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma

Br J Ophthalmol

Gallo B, Hussain R, Al-Jamal R, Khalid H, Stoker I, Hay G, Arora AK, Sagoo MS

doi: 10.1136/bjo-2023-324686

Macular DiseasesFurther Publications

Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema: The Vitrectomy in Diabetic Macular Oedema (VIDEO) Randomized Clinical Trial

JAMA Ophthalmol

Maguire MJ, Laidlaw A, Hammond C, Muqit MMK, Steel D, Dinah C, Lee E, Hillier R, Almeida G, Hussain R, Gordon-Bennet P, Hughes E, Alexander P, Vaideanu-Collins D, Jackson T

doi: 10.1001/jamaophthalmol.2024.2777

Retinal DiseasesFurther Publications

Ultra-Widefield and Early Treatment Diabetic Retinopathy Study 7-Field Grading of Diabetic Retinopathy

JAMA Ophthalmol

Aiello LP, Blodi B, Gao X, Sun JK, Gubitosi-Klug RA, White NH, Hainsworth D, Lorenzi GM, Bebu I, DCCT/EDIC Research Group

doi: 10.1001/jamaophthalmol.2024.2890

Macular Diseases

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis

Clin Exp Ophthalmol

Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA

doi: 10.1111/ceo.14559

Related content

Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy

Anti-vascular endothelial growth factor injections vs panretinal photocoagulation laser therapy for proliferative diabetic retinopathy - A systematic review and meta-analysis

Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database

Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy

Macular Capillary Nonperfusion in Eyes With Stable Laser-Treated Proliferative Diabetic Retinopathy

Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma

Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema: The Vitrectomy in Diabetic Macular Oedema (VIDEO) Randomized Clinical Trial

Ultra-Widefield and Early Treatment Diabetic Retinopathy Study 7-Field Grading of Diabetic Retinopathy

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis